Antimicrobial treatment of community-acquired pneumonia in the elderly

Jose A. Velez, Eric M. Mortensen, Antonio Anzueto, Marcos I. Restrepo

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Community-acquired pneumonia is a clinical diagnosis that has a significant impact on healthcare management around the world, especially in the fastest-growing segment of the population, those aged 65 or older. Early clinical suspicion and prompt empirical antimicrobial therapies are very important in patients with community-acquired pneumonia. This manuscript provides a review of the most recent literature published addressing etiological agents and antimicrobial management of community-acquired pneumonia in persons aged over 65 years with an emphasis on appropriate antimicrobial therapy for hospitalized elderly patients with community-acquired pneumonia.

Original languageEnglish (US)
Pages (from-to)999-1011
Number of pages13
JournalAging Health
Issue number6
StatePublished - Dec 1 2006


  • Aged
  • Anti-infective agents
  • Antibacterial agents
  • Antibiotics
  • Pneumonia
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Geriatrics and Gerontology


Dive into the research topics of 'Antimicrobial treatment of community-acquired pneumonia in the elderly'. Together they form a unique fingerprint.

Cite this